Showing results (2291-2300 of 2,350) with videos related to

Sort By:
Pageof 235
Oral Oncology|January 5, 2023
30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)T J Haller, X L Yin, T J O'Byrne, et al.
Blood|July 23, 2025
Fusion Oncoproteins and Cooperating Mutations Define Disease Phenotypes in NUP98-Rearranged LeukemiaMasayuki Umeda, Ryan Lea Hiltenbrand, Nicole L Michmerhuizen, et al.
Neuro-Oncology|September 8, 2025
Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patientsJu-Hee Oh, Sarah K Reed, Cecile Riviere-Cazaux, et al.
The British Journal of Dermatology|September 20, 2018
Subtype-specific inherited predisposition to pemphigus in the Chinese populationS Y Zhang, X Y Zhou, X L Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2024
Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic CancerLi Guan, Pedro A Torres-Saavedra, Xiaobei Zhao, et al.
Physical Review Letters|July 9, 2020
High-Brightness Continuous-Wave Electron Beams from Superconducting Radio-Frequency Photoemission GunI Petrushina, V N Litvinenko, Y Jing, et al.
Acta Neuropathologica|October 24, 2020
Brain arteriolosclerosisBrittney L Blevins, Harry V Vinters, Seth Love, et al.
AIDS Care|July 7, 2023
Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment eraJ Ma, B Luu, S A Ruderman, et al.
Nano Letters|February 2, 2017
Engineering the Structural and Electronic Phases of MoTe2 through W SubstitutionD Rhodes, D A Chenet, B E Janicek, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|July 15, 2025
[A phase Ⅲ clinical study to evaluate the efficacy and safety profile of antaitasvir phosphate combined with yiqibuvir in the treatment of adults with chronic hepatitis C]L Wei, J Shang, X An, et al.
Pageof 235